Ngā hua rapu - Steven A. Moore
- E whakaatu ana i te 1 - 20 hua o te 54
- Haere ki te Whārangi Whai Ake
-
1
What Every Neuropathologist Needs to Know: The Muscle Biopsy mā J. Stephen Nix, Steven A. Moore
I whakaputaina 2020Revisão -
2
-
3
-
4
-
5
-
6
-
7
Brain and Eye Malformations Resembling Walker–Warburg Syndrome Are Recapitulated in Mice by Dystroglycan Deletion in the Epiblast mā Jakob S. Satz, Rita Barresi, Madeleine Durbeej, Tobias Willer, Amy Turner, Steven A. Moore, Kevin P. Campbell
I whakaputaina 2008Artigo -
8
-
9
-
10
-
11
-
12
Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy mā Aaron A. Stence, Jon Thomason, Jonathan A. Pruessner, Ramakrishna Sompallae, Anthony N. Snow, Deqin Ma, Steven A. Moore, Aaron Bossler
I whakaputaina 2021Artigo -
13
Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes mā Deborah E. Williard, Shawn D. Harmon, Terry L. Kaduce, Meredith A. Preuss, Steven A. Moore, Michael E. Robbins, Arthur A. Spector
I whakaputaina 2001Artigo -
14
Disruption of the β-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2E mā Madeleine Durbeej, Ronald D. Cohn, Ronald F. Hrstka, Steven A. Moore, Valérie Allamand, Beverly L. Davidson, Roger A. Williamson, Kevin P. Campbell
I whakaputaina 2000Artigo -
15
Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells mā Ashley Earle, Tyler J. Kirby, Gregory Fedorchak, Philipp Isermann, Jineet Patel, Sushruta Iruvanti, Steven A. Moore, Gisèle Bonne, Lori L. Wallrath, Jan Lammerding
I whakaputaina 2019Artigo -
16
Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy mā Amy Yang, Bobby G. Ng, Steven A. Moore, Jeffrey S. Rush, Charles J. Waechter, Kimiyo Raymond, Tobias Willer, Kevin P. Campbell, Hudson H. Freeze, Lakshmi Mehta
I whakaputaina 2013Artigo -
17
Myopathic Lamin Mutations Cause Reductive Stress and Activate the Nrf2/Keap-1 Pathway mā George Dialynas, Om Kumar Shrestha, Jessica Ponce, Monika Zwerger, Dylan A. Thiemann, Grant H. Young, Steven A. Moore, Liping Yu, Jan Lammerding, Lori L. Wallrath
I whakaputaina 2015Artigo -
18
<i>GMPPB</i>-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation mā Braden S. Jensen, Tobias Willer, Dimah Saade, Mary O. Cox, Tahseen Mozaffar, Mena Scavina, Vikki Stefans, Thomas Winder, Kevin P. Campbell, Steven A. Moore, Katherine D. Mathews
I whakaputaina 2015Artigo -
19
Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification mā Kristin Wilson, Crystal Faelan, Janet C. Patterson‐Kane, Daniel G. Rudmann, Steven A. Moore, Diane E. Frank, Jay S. Charleston, Jon Tinsley, Geoffrey D. Young, Anthony J. Milici
I whakaputaina 2017Revisão -
20
Dystroglycan on Radial Glia End Feet Is Required for Pial Basement Membrane Integrity and Columnar Organization of the Developing Cerebral Cortex mā Timothy D. Myshrall, Steven A. Moore, Adam P. Ostendorf, Jakob S. Satz, Tom Kowalczyk, Huy Tien Nguyen, Ray A. M. Daza, Charmaine Lau, Kevin P. Campbell, Robert F. Hevner
I whakaputaina 2012Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Genetics
Gene
Medicine
Muscular dystrophy
Cell biology
Mutation
Pathology
Biochemistry
Dystroglycan
Internal medicine
Laminin
Extracellular matrix
Anatomy
Chemistry
Congenital muscular dystrophy
Endocrinology
Neuroscience
Phenotype
Dystrophin
Myopathy
Biopsy
Immunology
Limb-girdle muscular dystrophy
Muscle biopsy
Skeletal muscle
Central nervous system
Computational biology
Disease
Enzyme